SEC 13F Intelligence

Qiming U.S. Ventures Management, LLC / TRML

Qiming U.S. Ventures Management, LLC’s Tourmaline Bio Inc Position

Does Qiming U.S. Ventures Management, LLC own Tourmaline Bio Inc (TRML)? Yes — 741.7K shares worth $35M (+63.76% of its 13F portfolio) as of Q3 2025.

Position Value
$35M
Q3 2025
Shares
741.7K
% of Portfolio
+63.76%
Quarters Held
8
currently held

Position History TRML

Reported value by quarter
Q4 ’23: $17MQ4 ’23Q1 ’24: $17MQ1 ’24Q2 ’24: $10MQ2 ’24Q3 ’24: $19MQ3 ’24Q4 ’24: $15MQ4 ’24Q1 ’25: $11MQ1 ’25Q2 ’25: $12MQ2 ’25Q3 ’25: $35MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025741.7K$35M+63.76%
Q2 2025741.7K$12M+50.22%
Q1 2025741.7K$11M+48.83%
Q4 2024741.7K$15M+29.41%
Q3 2024741.7K$19M+37.12%
Q2 2024741.7K$10M+18.13%
Q1 2024741.7K$17M+18.94%
Q4 2023641.7K$17M+15.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Qiming U.S. Ventures Management, LLC’s full portfolio or all institutional holders of TRML.